Peru scandal: gaps in oversight of COVID vaccine trial
Cáceres, C.F.; Zavaleta, A.; Gonzáles, G.F.
Nature 592(7856): 685
2021
ISSN/ISBN: 0028-0836 PMID: 33907329 Document Number: 363874
Document emailed within 1 workday
Related Documents
Pérez, L.M.; Gandolfi, A. 2020: Vulnerable Women in a Pandemic: Paid Domestic Workers and COVID ‐19 in Peru Bulletin of Latin American Research 39(S 1): 79-83Saint-Laurent, F. 2011: The story behind autism and the MMR vaccine: a medical scandal in the news Perspective Infirmiere: Revue Officielle de l'Ordre des Infirmieres et Infirmiers du Quebec 8(5): 9
Bewley, S.; Rose, L.; Gøtzsche, P.; Blennerhassett, M.; Colquhoun, D.; Pryke, M.; Tindall, G.; Braillon, A.; Richmond, C.; Illman, J.; May, J. 2014: Time to halt an out of control trial with ineffective oversight Bmj 349: G5601
Nosten, F.; Luxemburger, C.; Kyle, D.E.; Ballou, W.R.; Wittes, J.; Wah, E.; Chongsuphajaisiddhi, T.; Gordon, D.M.; White, N.J.; Sadoff, J.C.; Heppner, D.G. 1996: Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group Lancet 348(9029): 701-707
Duong, M.C.; Nguyen, H.T.; Duong, M. 2022: Evaluating COVID-19 vaccine hesitancy: a qualitative study from Vietnam Diabetes and Metabolic Syndrome 16(1): 102363
Chattu, V.K.; Singh, B.; Kaur, J.; Jakovljevic, M. 2021: COVID-19 Vaccine, TRIPS, and Global Health Diplomacy: India's Role at the WTO Platform Biomed Research International 2021: 6658070
Bartolini, R.M.; Winkler, J.L.; Penny, M.E.; LaMontagne, D.S. 2012: Parental acceptance of HPV vaccine in Peru: a decision framework Plos one 7(10): E48017
Minkah, P.A.; Borg, A.; Ryan, G.W.; Goulding, M.; Perrone, D.; Castiel, M.; Rosal, M.C.; Lemon, S.C. 2023: Empowering Youth Vaccine Ambassadors to Promote COVID-19 Vaccination in Local Communities: a 7-Step Approach Health Promotion Practice 2023: 15248399231178542
Wilhelmson, B. 1993: Trial and error for pertussis vaccine. Does the new recombinant vaccine have superior qualities? Lakartidningen 90(26-27): 2458-2459
Andrasik, M.P.; Sesay, F.Albertina.; Isaacs, A.; Oseso, L.; Allen, M. 2020: Social Impacts among Participants in HIV Vaccine Trial Network (HVTN) preventive HIV vaccine trials Journal of Acquired Immune Deficiency Syndromes 2020
Vaccari, M.; Poonam, P.; Franchini, G. 2010: Phase IIi HIV vaccine trial in Thailand: a step toward a protective vaccine for HIV Expert Review of Vaccines 9(9): 997-1005
Schmitt-Grohé, S.; Stehr, K.; Cherry, J.D.; Heininger, U.; Uberall, M.A.; Laussucq, S.; Eckhardt, T. 1997: Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group Developments in Biological Standardization 89: 113-118
Bakari, M.; Munseri, P.; Francis, J.; Aris, E.; Moshiro, C.; Siyame, D.; Janabi, M.; Ngatoluwa, M.; Aboud, S.; Lyamuya, E.; Sandström, E.; Mhalu, F. 2013: Experiences on recruitment and retention of volunteers in the first HIV vaccine trial in Dar es Salam, Tanzania - the phase I/Ii HIVIS 03 trial Bmc Public Health 13: 1149
Lindsey, J.C.; Shah, S.K.; Siberry, G.K.; Jean-Philippe, P.; Levin, M.J. 2013: Ethical tradeoffs in trial design: case study of an HPV vaccine trial in HIV-infected adolescent girls in lower income settings Developing World Bioethics 13(2): 95-104
Bhadade, R.; Harde, M.; deSouza, R.; Kasbe, A.; Deshpande, C.; Dave, S.; Joshi, M.; Bharmal, R.; Madke, T. 2020: Appraisal of Critically Ill COVID-19 Patients at a Dedicated COVID Hospital Journal of the Association of Physicians of India 68(9): 14-19
Anonymous 1976: Peru. - Agreement between Peru and Brazil for the conservation of the flora and fauna of the Amazon territories of the Republic of Peru and the Federative Republic of Brazil. - 7 November 1975 Food and Agricultural Legislation 25(2): 85-86
Kintu, K.; Andrew, P.; Musoke, P.; Richardson, P.; Asiimwe-Kateera, B.; Nakyanzi, T.; Wang, L.; Fowler, M.G.; Emel, L.; Ou, S.-S.; Baglyos, L.; Gurunathan, S.; Zwerski, S.; Jackson, J.B.; Guay, L. 2013: Feasibility and safety of ALVAC-HIV vCP1521 vaccine in HIV-exposed infants in Uganda: results from the first HIV vaccine trial in infants in Africa Journal of Acquired Immune Deficiency Syndromes 63(1): 1-8
Wheeler, C.M.; Castellsagué, X.; Garland, S.M.; Szarewski, A.; Paavonen, J.; Naud, P.; Salmerón, J.; Chow, S.-N.; Apter, D.; Kitchener, H.; Teixeira, J.úl.C.; Skinner, S.R.; Jaisamrarn, U.; Limson, G.; Romanowski, B.; Aoki, F.Y.; Schwarz, T.F.; Poppe, W.A.J.; Bosch, F.X.; Harper, D.M.; Huh, W.; Hardt, K.; Zahaf, T.; Descamps, D.; Struyf, F.; Dubin, G.; Lehtinen, M.; Denham, I.; Garland, S.M.; Mindel, A.; O'Sullivan, M.; Skinner, S.R.; Waddell, R.; De Sutter, P.; Poppe, W.A.J.; Tjalma, W.; De Carvalho, N.S.; Naud, P.; Teixeira, J.C.; Aoki, F.Y.; Diaz-Mitoma, F.; Dionne, M.; Ferguson, L.; Miller, M.; Papp, K.; Ramjattan, B.; Romanowski, B.; Somani, R.; Apter, D.; Karppa, T.; Kudjoi, N.; Kyha-österlund, L.; Lehtinen, M.; Levanen, H.; Lönn 2012: Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial LANCET. Oncology 13(1): 100-110
Dane, D.S.; Dick, G.W.A.; Connolly, J.H.; Fisher, O.D.; McKeown, F.; Briggs, M.; Nelson, R.; Wilson, D. 1957: Vaccination Against Poliomyelitis with Live Virus Vaccines: 1. a Trial of TN Type Ii Vaccine. 2. a Trial of SM Type i Attenuated Poliomyelitis Virus Vaccine. 3. the Evaluation of TN and SM Virus Vaccines BMJ 1(5010): 59-74
Planas, M-Elena.; García, P.J.; Bustelo, M.; Carcamo, C.P.; Martinez, S.; Nopo, H.; Rodriguez, J.; Merino, M-Fernanda.; Morrison, A. 2015: Effects of ethnic attributes on the quality of family planning services in Lima, Peru: a randomized crossover trial Plos one 10(2): E0115274